ARKK vs TOVX
ARK Innovation ETF (ARKK) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
ARKK does not have a complete income-statement cache yet.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
ARKK currently screens at market cap $0. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the ARKK and TOVX stock pages for the full models.
Not investment advice.